Tag Archives: Aptamers Market research report

Europe Aptamers Market Size to hit $ 77.76 Mn by 2021

The Europe Aptamers Market was worth $ 31.25 Million in 2016 and estimated to reach $ 77.76 Million by the end of 2021 with a growing potential of 20.00 %.  Europe aptamers market is predicted to strong trend over the forecast Period. Growth in the market will be driven by increasing players in this region.

Browse market data tables and in-depth TOC of the Europe Aptamers Market to 2021 @http://www.marketdataforecast.com/market-reports/europe-aptamers-market-1136/

North America Aptamers Market Size to hit $ 103.07 Mn by 2021

The North America Aptamers Market was worth $ 48.03 Million in 2016 and estimated to reach $ 103.07 Million by the end of 2021 with a growing potential of 16.50 %.  Aptamers are oligonucleotides that bind to target protein, lipid, or nucleic acid molecules with a high specificity.

Browse Market data tables and in-depth TOC of the North America Aptamers Market to 2021 @ http://www.marketdataforecast.com/market-reports/north-america-aptamers-market-1135/

Global Aptamers Market is poised to reach $ 293 million by 2021 with a CAGR of 18.00%

According to the report Global Aptamers Market, published by Market Data Forecast, The Market was worth $ 128.03 million in 2016 and estimated to reach $ 293 million by the end of 2021 with a growing potential of 18.00 %.

Aptamers are oligonucleotides that bind to target protein, lipid, or nucleic acid molecules with a high specificity. Aptamers are generated quickly and applied in the inhibition, characterization of proteins and for specific detection. Aptamers can be used as pharmaceutical leads, functional proteomic levels with antibodies, detection reagents, and small molecules. Aptamers can be engineered to have higher specificity and affinity for number of targets.

Asia Pacific Aptamers Market is poised to reach $ 66 million by 2021

According to the report Asia – Pacific Aptamers Market, published by Market Data Forecast, The Market was worth $ 24 million in 2016 and estimated to reach $ 66 million by the end of 2021 with a growing potential of 22.50 %.

Asia – Pacific aptamers market is predicted to have the highest CAGR over the forecast Period. Growth in the market will be driven by increasing use of aptamers for diagnostics, therapeutics and drug discovery.

Middle East and Africa Aptamers Market to grow at a CAGR of 15.00% during 2016 to 2021

According to the report Middle East and Africa Aptamers Market, published by Market Data Forecast, The Market was worth $ 9.53 million in 2016 and estimated to reach $ 11.82 million by the end of 2021 with a growing potential of 15.00 %. In the following years, the market is projected to grow enormously with Low cost of manufacturing, high efficacy of aptamers.

Latin America Aptamers Market to grow at a CAGR of 17.50% during 2016 to 2021

The Latin America Aptamers Market was worth $ 15.30 million in 2016 and estimated to reach $ 34.27 million by the end of 2021 with a growing potential of 17.50 %.  Increasing usage of aptamers is the major factor that driving the growth Latin America region.

Browse market data tables and in-depth TOC of the Latin America Aptamers Market to 2021 @http://www.marketdataforecast.com/market-reports/latin-america-aptamers-market-1138/

Europe Aptamers Market is estimated to reach $ 77.76 Million by 2021 | Market Data Forecast

The Europe Aptamers Market was worth $ 31.25 Million in 2016 and estimated to reach $ 77.76 Million by the end of 2021 with a growing potential of 20.00 %.  Europe aptamers market is predicted to strong trend over the forecast Period. Growth in the market will be driven by increasing players in this region.

Aptamers are oligonucleotides that bind to target protein, lipid, or nucleic acid molecules with a high specificity. Due to increasing number of opportunities I.e, drug discovery, biomarker discovery, and diagnostics segments in the market number of players entering into the market. The potential of aptamers in diagnostics and therapeutics has been recognised by the launch of first aptamer, Macugen. So, the European market for aptamers is expected to grow, which has been backed by advancements in technology with respect to selection processes and synthesis.

North America Aptamers Market is estimated to reach $ 103.07 Million by 2021 | Market Data Forecast

The North America Aptamers Market was worth $ 48.03 Million in 2016 and estimated to reach $ 103.07 Million by the end of 2021 with a growing potential of 16.50 %.  Aptamers are oligonucleotides that bind to target protein, lipid, or nucleic acid molecules with a high specificity.

The enormous opportunities offered by the market for the key players are the drug discovery, biomarker discovery, and diagnostics segments. The launch of Macugen, the first aptamer drug and the first diagnostic test for testing mycotoxins in grains has recognised the potential of aptamers in diagnostics and therapeutics. So, the market for aptamers is expected to grow, backed by technological advancements with respect to selection processes and synthesis.

Global Aptamers Market is expected to reach $ 293 million market by 2021 | Market Data Forecast

The Global Aptamers Market was worth $ 128.03 million in 2016 and estimated to reach $ 293 million by the end of 2021 with a growing potential of 18.00 %.  Aptamers are oligonucleotides that bind to target protein, lipid, or nucleic acid molecules with a high specificity. Aptamers are generated quickly and applied in the inhibition, characterization of proteins and for specific detection. Aptamers can be used as pharmaceutical leads, functional proteomic levels with antibodies, detection reagents, and small molecules. Aptamers can be engineered to have higher specificity and affinity for number of targets.